The effect of Dexmedetomidine in pediatric Electroconvulsive therapy

Phase 3

Recruiting

• Conditions: Condition 1: Blood Pressure. Condition 2: Heart Rate.; Elevated blood-pressure reading, without diagnosis of hypertension; R03.0; Tachycardia, unspecified; R00.0

• Registration Number: IRCT20160307026950N29
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Children 4 to 16 years
Candidate for ETC
ASA Class I & II

Exclusion Criteria

Patients with a history of seizures, Heart failure, Kidney failure, Liver failure, Respiratory failure
History of allergy to the studied drugs
Addiction to psychotropic substances
History of egg allergy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart Rate. Timepoint: Before drug injection and 1, 2, 3, 5 and 10 minutes after anesthesia. Method of measurement: ECG.;Blood Pressure. Timepoint: Before drug injection and 1, 2, 3, 5 and 10 minutes after anesthesia. Method of measurement: Manometer.

Secondary Outcome Measures

Name	Time	Method
Duration of anesthesia. Timepoint: From the beginning of anesthesia to the end of recovery. Method of measurement: Timer.;Duration of seizures. Timepoint: From the moment of the beginning of contractions until the time of relaxation. Method of measurement: Timer.